(Q45231506)

English

Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene delivery

scientific article published in February 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene delivery (English)

1 reference

Europe PubMed Central

11 December 2017

1 reference

based on heuristic

inferred from title

Akseli Hemminki

2

object named as

Akseli Hemminki

1 reference

Europe PubMed Central

11 December 2017

David T. Curiel

8

object named as

David T Curiel

1 reference

Europe PubMed Central

11 December 2017

3

object named as

Gene P Siegal

1 reference

Europe PubMed Central

11 December 2017

author name string

Minghui Wang

1

1 reference

Europe PubMed Central

11 December 2017

Mack N Barnes

4

1 reference

Europe PubMed Central

11 December 2017

Igor Dmitriev

5

1 reference

Europe PubMed Central

11 December 2017

Victor Krasnykh

6

1 reference

Europe PubMed Central

11 December 2017

Bin Liu

7

1 reference

Europe PubMed Central

11 December 2017

Ronald D Alvarez

9

1 reference

Europe PubMed Central

11 December 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

11 December 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

11 December 2017

96

1 reference

Europe PubMed Central

11 December 2017

2

1 reference

Europe PubMed Central

11 December 2017

341-348

1 reference

Europe PubMed Central

11 December 2017

Human gene marker/therapy clinical protocols (complete updated listing)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Immune responses to adenovirus and adeno-associated virus in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Serum and ascites neutralizing antibodies in ovarian cancer patients treated with intraperitoneal adenoviral gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Adenoviral vector-mediated gene transfer for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Adenovirus-mediated regulable target gene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Pseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Targeting adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Worldwide epidemiology of human adenovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Adenovirus antigens: a model system in mice for subunit vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

The relationship between the soluble antigens and the virion of adenovirus type 3. IV. Immunological complexity of soluble components.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Immunological adenovirus variant strains of subgenus D: comparison of the hexon and fiber sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

based on heuristic

inferred from DOI database lookup

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Virus-Receptor Interaction in an Adenovirus System

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YGYNO.2004.09.063

1 reference

Europe PubMed Central

11 December 2017

1 reference

Europe PubMed Central

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45231506&oldid=2070742491"